Sorrento Therapeutics Inc

Most Recent

  • sorrento therapeutics stock

    Sorrento Therapeutics' Stock Price Continues to Climb

    Sorrento Therapeutics stock has surged 450 percent year-to-date. See what our analysts suggest for the stock. Will the rally continue?
    By Ambrish Shah
  • is sorrento therapeutics a good bet

    Is Sorrento Therapeutics a Good Bet for Investors?

    Sorrento Therapeutics stock has surged 280 percent year-to-date. Will the rally continue?

    By Ambrish Shah
  • uploads///SRNE
    Company & Industry Overviews

    Why the Sudden Surge in Sorrento Therapeutics’ Revenue?

    In fiscal 2017, Sorrento Therapeutics (SRNE) generated total revenue of $151.8 million compared to $8.1 million in fiscal 2016.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.